Study title:
Evaluation of efficacy of Salmonella Dublin-Typhimurium vaccine, double gene deleted avirulent live culture in calves.
EU record number:
B/BE/01/V6
Company / Sponsor:
Pharmacia Animal health
Treated organism:
calves
Indication category:
vaccination against Salmonella Dublin and Salmonella Typhimurium
Genetic modification:
genetic modification of Salmonella enterica by deletion of 2 genes (ssaC and ssaT)
Method of transfer of nucleic acid of interest:
Salmonella enterica serotype Dublin and Salmonella enterica serotype Typhimurium
Route of administration:
subcutaneous
Locations in Belgium:
2 farms located in Flanders were to be selected
Nr of subjects:
100
Foreseen duration:
12 months
Type of procedure:
Deliberate release only
Information for the public
-
Public information presented according to the provisions of Directive 2001/18/EC
-
-
B/BE/01/V6 - Summary Notification Information Format (SNIF)Information related to the decision procedure
-
4 February 2002: The Biosafety Advisory Council a.i. issues a negative advice for this trial (the advice is written in French and Dutch)